Q4 2023 Holdings
Filed 2024-01-05 | 7 holdings | $84.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Centessa Pharmaceuticals plc(CNTA) | Ordinary Shares | 152309100 | $31.3M | 3,931,818 | 37.3% |
| Dyne Therapeutics, Inc.(DYN) | Common Stock | 26818M108 | $27.6M | 2,074,787 | 32.9% |
| LianBio | Ordinary Shares | 53000N108 | $10.2M | 2,282,084 | 12.1% |
| Allogene Therapeutics, Inc.(ALLO) | Common Stock | 019770106 | $5.8M | 1,798,163 | 6.9% |
| Kinnate Biopharma, Inc. | Common Stock | 49705R105 | $5.2M | 2,207,772 | 6.2% |
| Kronos Bio, Inc.(KRON1USD) | Common Stock | 50107A104 | $3.5M | 2,765,314 | 4.1% |
| Ikena Oncology, Inc. | Common Stock | 45175G108 | $443.6K | 225,192 | 0.5% |